Navigation Links
Spherix Announces Results of Annual Shareholders Meeting
Date:11/19/2009

to successfully commercialize D-tagatose. We believe we are on the right path and we're working diligently to get there."

Dr. Kruger, CEO, added, "I am proud to report that Spherix has reached a number of key milestones, each of which we hope will increase the potential for the Company to realize its goal of commercializing D-tagatose as a novel treatment option for patients with Type 2 diabetes."

Dr. Lodder, President, elaborated on the results of the compound's recent interim analysis, "Results of the blinded interim data analysis of the Phase 3 trial demonstrate a significant reduction in variability of HbA1c levels, the primary endpoint of the trial, increasing the statistical power to observe a significant result. The observed data to-date indicate that the change in variability of HbA1c from baseline is favorable, and that the current sample size gives the study sufficient power to achieve the statistical significance for protocol defined differences between control and D-tagatose in HbA1c when the study reaches the planned number of patients completing treatment.

"The analysis noted that the results of the secondary variables, LDL, HDL, triglycerides, and body mass index (BMI), are very striking and are in agreement with that of the HbA1c results. These results demonstrate a significant decrease in the mean BMI at all time points evaluated compared to baseline. A consistent decrease of BMI and serum triglycerides was observed at each visit, with the difference in triglycerides becoming significant by the last two patient visits. A statistically significant reduction in HDL and LDL was also seen compared to baseline."

Dr. Kruger concluded the Company's formal remarks by saying, "Turning now to our ongoing and developing commercialization strategy, there is no point in doing clinical trials unless the company plans to market the drug as a result. The Company needed to raise $6.3 million in new capital on Monday
'/>"/>

SOURCE Spherix Incorporated
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Spherix Shareholders Support Companys Focus on Naturlose, Biotechnology
2. Spherix Reports 3rd Quarter Earnings
3. Spherix Reports 2007 Financial Results
4. Spherix Hires Key Employees
5. Spherix Holds Annual Shareholders Meeting
6. Spherix Reports 1st Quarter Earnings
7. Spherix Receives NASDAQ Bid Price Deficiency Letter
8. Spherix Receives Nasdaq Letter Extending Minimum Bid Price Compliance Period
9. Spherix Transfers Stock Listing to Nasdaq Capital Market
10. Spherix Reports 3rd Quarter Earnings
11. Spherix Announces 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)...  NuGene International, Inc. ("NuGene") (OTCQB: NUGN), the ... hair rejuvenation, has announced that it has selected ... investor relations and strategic communications. ... diversification strategies – and we need to communicate ... Ali Kharazmi CEO of NuGene when announcing this ...
(Date:2/26/2015)... BioEnterprise today announced that Northeast Ohio ... in growth funding during the past 13 years.  Funding ... – including the Ohio Third Frontier - and federal ... raised in the past five years. ... BioEnterprise Midwest Healthcare Growth Capital  Report.   ...
(Date:2/26/2015)... 2015 Already well respected for accuracy, ... expanding its Length Gauge offerings with new variants of ... , Specifically, HEIDENHAIN’s pencil probe-style SPECTO length gauge series ... Two new 1Vpp, 12mm stroke length variants of the ... is a variant with a weak spring, 0.4N of ...
(Date:2/26/2015)... 2015 RURO, Inc., a leading LIMS, ... 6.2 – the latest update to the bestselling commercial-off-the-shelf ... of a quick and easy method to gain better ... version, RURO engineering has enhanced the system’s support for ... amounts of sample records. , "FreezerPro has become ...
Breaking Biology Technology:NuGene International, Inc. Selects Capital Market Relations for Strategic Investor Relations 2NuGene International, Inc. Selects Capital Market Relations for Strategic Investor Relations 3More Than $2 Billion Invested in Northeast Ohio Bioscience Start-Up Companies Since 2002 2More Than $2 Billion Invested in Northeast Ohio Bioscience Start-Up Companies Since 2002 3More Than $2 Billion Invested in Northeast Ohio Bioscience Start-Up Companies Since 2002 4Accuracy and Versatile Gauging Go Hand in Hand at HEIDENHAIN 2RURO Releases FreezerPro® version 6.2 2
... LONDON, August 11, 2011 Pharma IQ is pioneering ... compound management event - Compound Management and Integrity Online ... over the course of 5 weeks, beginning 31 ... compound management and integrity process is high on the agenda for ...
... , A national team of experts, led by ... a multi-million-dollar grant to bring unrivaled qualities found ... , The scientists goal is to produce new ... high-efficiency batteries, ultracapacitors, fuel cells and hydrogen storage ...
... 2011 Exagen Diagnostics, Inc. , a specialty ... proprietary tests for rheumatologists and gastroenterologists, announced today the ... Officer. Tornoe has more than 20 years ... marketing, making him a key hire as Exagen broadens ...
Cached Biology Technology:Compound Management and Integrity Goes Online 2Compound Management and Integrity Goes Online 3Teaming up to build 3-D nanomaterials 2Teaming up to build 3-D nanomaterials 3Eric Tornoe Joins Exagen Diagnostics as President and COO 2
(Date:2/19/2015)... 2015 Research and Markets ( ... "Military Electro-Optical / Infrared Systems Market by ... - Forecast to 2020" report to their ... market is expected to reach $16.35 billion by ... This report segments the military electro-optical/infrared systems ...
(Date:2/12/2015)... NXT-ID, Inc. (NASDAQ: NXTD ... company focused on the growing mobile commerce market, announced ... DISTRIBUTED METHOD AND SYSTEM TO IMPROVE COLLABORATIVE ... establishes NXT-ID,s position in the emerging "Internet of Things" ... for multiple devices to collaborate with one another to ...
(Date:2/5/2015)... , 5. Februar 2015 ... spezialisiertes Logistikunternehmen und hat eine neue Marketingkampagne ... Logistikfirma (Clinical Logistics Organization – CLO) der ... Kampagne lautet First , mit Schwerpunkt ... Foto: http://photos.prnewswire.com/prnh/20150205/173753 Logo ...
Breaking Biology News(10 mins):Military Electro-Optical / Infrared Systems (Image Intensification, Laser, Infrared) Market - Forecast to 2020: Featuring Profiles of the Market Leaders on this $16 Billion market 2Military Electro-Optical / Infrared Systems (Image Intensification, Laser, Infrared) Market - Forecast to 2020: Featuring Profiles of the Market Leaders on this $16 Billion market 3NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 2NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 3Marken startet Kampagne mit Patienten im Mittelpunkt 2Marken startet Kampagne mit Patienten im Mittelpunkt 3
... Arizona farmers receive the same yield/acre, use fewer chemical ... biotech cotton known as Bt cotton, according to new ... study that simultaneously examined how growing Bt cotton affects ... the environment. , "What we see is that it's ...
... An important source of uncertainty in predictions about global ... carbon dioxide. Now biologists at the University of California, ... mechanism plants use to regulate their carbon dioxide intake. ... early on-line edition of the journal Proceedings of the ...
... Hughes Medical Institute (HHMI) international research scholar in Israel ... so hard to stop. , Emanuel Hanski, a ... found that the success of Group A Streptococcus is ... immune system's distress calls. The findings, published in the ...
Cached Biology News:Biotech cotton provides same yield with fewer pesticides 2Biotech cotton provides same yield with fewer pesticides 3UCSD study reveals how plants respond to elevated carbon dioxide 2UCSD study reveals how plants respond to elevated carbon dioxide 3Solved: The mystery of flesh-eating bacteria's relentless attack 2Solved: The mystery of flesh-eating bacteria's relentless attack 3
... High Performance, 5 ml. The same ... HiTrap Streptavidin columns for fast, reliable ... into Tricorn 5/50 GL, XK 16/20, ... purifications are required.Extremely useful for exploiting ...
...
...
Request Info...
Biology Products: